Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HEROLD

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Low-dose gamma-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burdenW E Aulitzky, J Lerche, A Thews, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trialW E Aulitzky, H Tilg, G Gastl, et al.
Immunobiology|December 1, 1990
Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC moleculesE Pócsik, R Mihalik, M Réti, et al.
Biomacromolecules|January 23, 2018
In Vivo Coating of Bacterial Magnetic Nanoparticles by Magnetosome Expression of Spider Silk-Inspired PeptidesFrank Mickoleit, Christian B Borkner, Mauricio Toro-Nahuelpan, et al.
ACS Applied Materials & Interfaces|May 6, 2020
Surface Modification of Spider Silk Particles to Direct Biomolecular Corona FormationAlessia C G Weiss, Heike M Herold, Sarah Lentz, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2022
Identification of potent and selective inhibitors of PKR via virtual screening and traditional designK P Cusack, M A Argiriadi, T D Gordon, et al.
Toxicology Letters|November 12, 2018
Added value of plasma metabolomics to describe maternal effects in rat maternal and prenatal toxicity studiesJ Keller, W Mellert, S Sperber, et al.
Annals of Hematology|November 1, 1993
Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemiaW E Aulitzky, C Peschel, D Desprès, et al.
Journal of Hepatology|September 1, 1993
Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effectsH Tilg, W Vogel, J Tratkiewicz, et al.
Cytokine|August 1, 1995
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cellsF A Offner, P Obrist, S Stadlmann, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Low-dose gamma-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burdenW E Aulitzky, J Lerche, A Thews, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trialW E Aulitzky, H Tilg, G Gastl, et al.
Immunobiology|December 1, 1990
Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC moleculesE Pócsik, R Mihalik, M Réti, et al.
Biomacromolecules|January 23, 2018
In Vivo Coating of Bacterial Magnetic Nanoparticles by Magnetosome Expression of Spider Silk-Inspired PeptidesFrank Mickoleit, Christian B Borkner, Mauricio Toro-Nahuelpan, et al.
ACS Applied Materials & Interfaces|May 6, 2020
Surface Modification of Spider Silk Particles to Direct Biomolecular Corona FormationAlessia C G Weiss, Heike M Herold, Sarah Lentz, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2022
Identification of potent and selective inhibitors of PKR via virtual screening and traditional designK P Cusack, M A Argiriadi, T D Gordon, et al.
Toxicology Letters|November 12, 2018
Added value of plasma metabolomics to describe maternal effects in rat maternal and prenatal toxicity studiesJ Keller, W Mellert, S Sperber, et al.
Annals of Hematology|November 1, 1993
Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemiaW E Aulitzky, C Peschel, D Desprès, et al.
Journal of Hepatology|September 1, 1993
Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effectsH Tilg, W Vogel, J Tratkiewicz, et al.
Cytokine|August 1, 1995
IL-6 secretion by human peritoneal mesothelial and ovarian cancer cellsF A Offner, P Obrist, S Stadlmann, et al.
Pageof 28